Related Experiment Video

Updated: Jun 8, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Targeting microRNAs in cancer: rationale, strategies and challenges

Ramiro Garzon1, Guido Marcucci, Carlo M Croce

  • 1Division of Haematology and Oncology, Department of Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43221, USA. ramiro.garzon@osumc.edu

Nature Reviews. Drug Discovery
|October 2, 2010
PubMed

Insights

MicroRNAs (miRNAs) are small molecules that regulate genes. Targeting miRNA expression offers a promising strategy for developing novel anticancer therapies due to their ability to affect multiple cancer-related pathways.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small, non-coding RNA molecules that play crucial roles in gene expression regulation.
  • Aberrant miRNA expression is frequently observed in various types of cancer, contributing to tumorigenesis.
  • Experimental evidence suggests that modulating miRNA levels can alter cancer phenotypes.

Purpose of the Study:

  • To review the role of miRNAs in cancer development (tumorigenesis).
  • To critically evaluate the strategies and challenges associated with developing miRNA-based cancer therapies.
  • To discuss the potential of miRNA targeting as a therapeutic approach in oncology.

Main Methods:

  • Literature review of existing studies on miRNAs in cancer.
  • Analysis of experimental data demonstrating the impact of miRNA modulation on cancer.
  • Discussion of current and emerging therapeutic strategies targeting miRNAs.

Main Results:

  • miRNAs are key regulators of cellular processes including differentiation, proliferation, and survival.
  • Dysregulated miRNAs are implicated in the initiation and progression of cancer.
  • Targeting miRNAs can modify cancer phenotypes and offers therapeutic potential.

Conclusions:

  • miRNA-based therapies hold promise for cancer treatment, potentially by targeting multiple oncogenic pathways simultaneously.
  • Combining miRNA therapeutics with existing treatments may improve patient outcomes and increase cure rates.
  • Further research is needed to overcome challenges and optimize miRNA-targeting strategies for clinical application in cancer.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...